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A new class of forskolin derivatives have been synthesized based on 2- hydroxy ethyl spacer and 2-
dialkylaminomethyl chain had incorporated for promoting water solubility. The synthetic strategy
involves the regiospecific epoxide ring opening reaction with Hel in acetonitrile or by secondary amine.
None of the compounds shows interesting biological activity.
During our earlier structure activity relationship
studies on forskolin derivatives, we had shown that
positive inotropic activity of forskolin could be
improved by hydroxyacetyl spacer at 6~- or 7~-
position of forskolin' (Figure 1). Considering this
idea we had developed highly potent water soluble
orally active forskolin analogs". However one of
the major difficulty associated with these
compounds was their unstability in aqueous
solution.
To overcome this shortcoming we wanted to
replace hydroxyacetyl group by far more stable
hydroxy alkyloxy group as 'spacer'. Therefore, we
adopted a strategy to synthesize new forskolin
analogs where the 7~- acetyl group could be shifted
away from the ring by the addition of 2-
hydroxyethyloxy chain as shown by the bold line in
Figure 2. To retain the earlier idea of having
stability and water solubility, we had chosen
aminoalkyl chain as one of the appendages as
shown in dotted line in Figure 2. In this paper we
would like to describe the synthetic strategy for
such compounds and the influence of these changes
on biological activity.
Chemistry
The suitable synthetic route for the synthesis of
such compounds could be the ring opening reaction
on epoxide 13 as shown in the Scheme 1. Initially
we had chosen the ring opening reaction with HCl
in organic solvents to generate chlorohydrin", The
regioselectivity of this reaction is largely dependent
upon the nature of the substituent present on
epoxides-8. However, when epoxide on terminal
double bond is opened, the chlorine usally gets
attached to the terminal position. Such observation
could be found in the literature where ethyl 3,4-
epoxybutyrate gave 3-chloro-2-hydroxybutyrate as
the major product". Since our system is close to
that reported in the literature, we could expect a
similar reaction to generate the key intermediate.
Thus, when 1 was reacted with 12% aqueous HCI
in acetonitrile we could get the required
chlorohydrin 3 in a regioselective manner with
concomitant loss of l o-silyl group. The IH NMR
spectrum indicated the correct regiochemistry of
compound 3. Still it was necessary to prove beyond
doubt the correct isomer before continuing further.
Therefore, we chose another substrate 23 to get a
less complex IH NMR spectrum. Thus, 2 had
reacted with 12% aqueous HCI in acetonitrile as
described earlier to give compound 4 which
showed a doublet at 8 3.66 corresponding to
CH2CI, a one-proton multiplet around 3.62-3.96
assigned to CH(OH) and two sets of multiplets at 8
3.98-4.23 integrating to two protons which were
due to the protons of CH2 attached to 7~-position.
These signals indicate that chlorine got attached to
the terminal position. This was further confirmed
by acylation of the secondary hydroxyl group by
reacting 4 with formic or acetic acid in the
presence of DCC-DMAP (Scheme J) to yield Sa
and Sb respectively. Analysis of IH NMR data of
Sa and Sb showed a down-field shift of the proton
due to attachment of electron-withdrawing formyl
or acetyl group at i-CH(OH)- position. In Sa it






















Fig 1: In vitro positive inotropic activity of forskolin and some of its
analogs synthesized earlier based on 2-hydroxy acetyl "spacer" I,2
Fig. 2
appeared at 8 5.26-5.46 and at 85.06-5.34 in 5b as
multiplets corresponding to one proton. The
doublet ofCH2Cl protons appeared at 8 3.82 for Sa
and at 3.83 for 5b respectively. We have also
observed well separated jeminal coupling for OCH2
protons attached to 7f3-position (see Experimental).
Coming back to original substrate when 3 had
reacted with AcOH in the presence of DCC-
DMAP, product 6 was obtained as shown in
Scheme I. The IH NMR of this compound also
showed a substantial down-field shift of CH(OAc)
proton at 8 5.11-5.31 in comparison to 8 3.71-4.13
for CH(OH) proton observed for compound 3. The
doublet for CH2Cl appeared at 8 3.77 which was
very close to the value observed for 3 (8 3.61).
These data clearly established the structure of 3.
The key intermediate 6 was then utilized to get the
target compounds by replacing chlorine by
different amines. Thus, 6 was reacted with
dimethyl amine in toluene-dichlorornethane at
room temperature to get 7 in poor yield. The poor
yield was due to side reactions including hydrolysis
of the acetyl group. The other alternative strategy
could be to replace Cl by amine in 3 followed by
acetylation. This strategy was not pursued due to
possibility of side reactions such as epoxidation as
well as acetylation at 1a-position. The later
reaction contributes significantly when the terminal
position contains a bulky group (unpublished
result). In the meantime we were looking for an
alternative approach which involved opening of the
epoxide ring with the required amine with 1a-
protection intact, followed by acetylation. The final
compound could be obtained by silyl deprotection.
Thus, compound 1 was treated with different
secondary amines in CH2Ch at room temperature
to obtain 8 to 11 (Scheme II) in excellent yields.
Compounds 8-11-were converted to the acetyl
derivatives 12-15 by the reaction of acetic acid in
the presence of DCC-DMAP as described earlier.
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5a; RI = R9= H; R7= H
5a; RI = R9= H; R7= CH3
2; RI = R9= OH; R7= CH3
Scheme I. 1. 12 % aq.HCI, CH3CN, room temperature. 2. Acetic acid, DCC, DMAP, EtOAc,
room temperature. 3. Me2NH in toluene, CH2CI2, room temperature.
Once again the regiospecific ring opening could be
established by the down-field shift of proton
attached to the secondary alcohol after acetylation
(see IH NMR values in Experimental Section).The
deprotection of silyl group'" from 8-11 gave the
final compounds 16-19 with free hydroxy at 7f3
side chain and 12, 14, 15 were converted to 7, 20
and 21 respectively as shown in Scheme ll.
All the compounds were found to be readily
soluble in water. The aqueous solution did not
show any decomposition after keeping at room
temperature for 24 hr. All these compounds, having
free hydroxy or acetoxy group at 7f3-side chain,
were tested for positive inotropic and blood
pressure lowering activity. None of the compounds
however, showed any interesting biological
activity. This clearly demonstrated that for
retaining biological activity, one needs an acyl
(OCOR) functionality directly attached to the 7f3-
position. Conversion of acyl to alkyl chain almost
demolishes the biological activity.
In conclusion, we have completed the synthesis
of a new class of water soluble forskolin analogs
with 2-hydroxyethyloxy 'spacer'. This was
achieved through a regioselective epoxide ring
opening. This modification carried out on forskolin
however failed to retain the biological activity of
forskolin.
Experimental Section
General. Melting points were determined on a
Kofler hot stage apparatus and are uncorrected. IR
spectra were determined on a Perkin-Elmer 157
spectrophotometer as KBr film unless otherwise
mentioned. IH NMR spectra were recorded in
CDCh unless otherwise mentioned on a lEOL FT-
90 spectrometer with TMS as internal standard
(chemical shifts in 0, ppm and coupling constant









16; NR2 = NMe2; 17; NR2 = NEt2





2; NR2 = NEt2
10; NR2 = Piperidino;!!; NR2 = Morpholino
TBDMSO
OH
12; NR2 = NMe2; 13; NR2 = NEt2





1; NR2 = NMe2; 20; NR2 = Piperidino;
21; NR2 = Morpholino
Scheme n I. R2NH, CH2CI2, r.t. 2. AcOH, DCC, DMAP,
EtOAc, r.t. 3. 1M nBu4N+F-, THF, r.t. 4. HCI-ether, EtOAc.
values in Hz). Petroleum ether refers to the fraction
of bp 60-80°C. For flash column chromatography
silica gel (finer than 0.08 mm particle size) was
used. Precoated (silica gel 60 F254)TLC plates were
used for checking purity of the compounds.
Vaniline-50% orthophosphoric acid or
anisaldehide-Hybf), spray reagent was used and the
plates were heated at 110°C for visualization. All




pound 1 (1.4 g; 2.6 mmol) was dissolved in
CH3CN (55 ml) and 12% aqueous HCI (5.5 mL)
was added. The reaction mixture was stirred at
room temperature for 2 h. Solvent was removed
after neutralizing excess HCI by adding NaHCO:,
solution. The residue was extracted with EtOAc
(3x 10 mL). The combined organic layer was
washed with brine and dried over anhydrous
Na2S04. The solvent was removed and the residue
purified by flash chromatography using 10%
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CH3CN in CHCI3 as eluents yield, 1.08 g (83.5%),
semisolid; IR (KBr): 3500-3400 (br), 2950 (br),
1720 cm"; IH NMR: 1.09, 1.29, 1041, 1.44, 1.67
(5xs, I5H, 5xCH3), 2.07 (d, IH, J=2.53, 5-H),
2048,2049 (2xd*, IH, Jgem=16.2, 12-[3H), 3.18, 3.19
(2xd*, IH, Jgem=16.2, 12-aH), 3.61 (t, 2H, J=5.06,
CH2CI), 3.71-4.13 [m, 4H, 7H and
OCH2CH(OH)CH2CI], 4043 (dd, IH, J=3.04, 2.53,
6-H), 4.61 (br, IH, I-H), 4.99 (dd, IH, Jcis=I1.14,
Jgem=1.62, 15-Hcis), 5.16 (dd, IH, .ftram·=17.6,
Jgem=1.62, 15-lftrans), 6.12, 6.14 (2xdd*, IH,
J,rans=17.6, Jci.,·=11.14, 14-H), 6.56,6.69 (2xbr, 2H,
exchangable, 2xOH). Anal. CaJcd for C23H3707CI:
C, 59.92; H, 8.09; CI, 7.69. Found: C, 59.79; H,
7.93; CI, 7.S8% (* due to diastereoisomers).
7[>-(3-Chloro-2-hydroxypropyloxy)-S,13-epoxy-
6[>-hydroxy-labd-14-en-ll-one 4. This compound
was prepared according to the method described
above starting from 2. The crude product was
purified by flash chromatography using 5%
CH3CN in CHCh as eluent, yield 85.8%,
semisolid; IR (KBr): 3S00 (br), 3420 (br), 2980
(br), 1720 cm'; IH NMR: 0.79 (d, IH, J=2.03, 5-
H), 1.01, 1.24, 1.36, 1.41, 1.57 (5xs, 15H, 5xCH3),
2.63 (s, IH, 9-H), 2.69 (s, 2H, 12-H2)' 3045 (d, IH,
J=4.05, 7-H), 3.66 (d, 2H, J=S.06, CH2CI), 3.62-
3.96 [m, IH, -CH(OH)], 3.98-4.23 [2xm, 2H,
OCH2CH(OH)], 4.36 (dd, IH, J=4.05, 2.03, 6-H),
5.06 (dd, IH, Jci.,·=11.14, Jgem=1.02, 15-Hei.,), 5.13
(dd, 1H, .ftram=17.2, Jgem= 1.02, 15-Hlrans), 5.96 (dd,
IH, .ftran,=17.2, Jeis=11.14, 14-H); Anal. CaJcd for
C23H370SCI:C, 64.39; H, 8.69; CI, 8.26. Found: C,
64.31; H, 8.65; CI, 8.12%.
7[>-(3-Chloro-2-fonnyloxypropyloxy)-S,13-epoxy-
6[>-hydroxy-labd-14-en-ll-one Sa. Compound 4
(0.215 g, 0.5 mmol) and DCC (0.138 g, 0.67
mmol) were dissolved in EtOAc (10 mL). Formic
acid (0.023 mL, 0.61 mmol) was added to the
vigorously stirred solution at room tempetature
followed by DMAP (0.1 g; 0.82 mmol). After
stirring for 3 h at room temperature, the reaction
mixture was kept in the freezer overnight. The
DCU was filtered off and the filtrate washed with
brine. It was dried over anhydrous Na2S04.The
residue after removing solvent was purified by
flash chromatography using 15% EtOAc in light
petroleum as eluent. It was crystallized from
EtOAc-light petroleum, yield 0.19 g (83%); mp,
9S-98°C; IR (KBr): 3S30 (br), 2940 (br), 173S,
1710 cm'"; IH NMR: 0.91 (d, lH, J=2.03, S-H),
1.0, 1.23, 1.30, lAO, I.S1 (Sxs, ISH, SxCH3), 1.97
(s, IH, exchangable, OH), 2.S7 (s, IH, 9-H), 2.61
(s, 2H, 12-H2), 3.39 (d, IH, J=4.0S, 7-H), 3.82 (d,
2H, J=S.OS, CH2CI), 3.99, 4.19 [2xt, 2H,
Jgem=I1.14, J=S.OS, OCH2CH(OCHO)], 4.34 (dd,
IH, J=4.0S, 2.03, 6-H), S.03 (dd, IH, Jeis=10.13,
Jgem= 1.82, IS-He;"), S.14 (dd, IH, J1rans=17.2,
Jgem=1.82, IS-Hiram), S.26-SA6 [m, IH,
CH(OCHO)], S.9S (dd, IH, J,ran,=17.2, Jcis=I1.13,
14H), 8.11 [s, IH, CH(OCHO)]; Anal. CaJcd for
C24H3706CI: C, 63.07; H, 8.16; CI, 7.76. Found: C,
62.88; H, 8.16; CI, 7.93%.
7[>-(2-Acetoxy-3-chloropropyloxy)-8,13-epoxy-
6[>-hydroxy-labd-14-en-ll-one Sb..This compound
was prepared from 4 by the same method as
described above using AcOH in place of formic
acid, yield 8S.7%; mp, 99-101oC (EtOAc-light
petroleum); IR (KBr): 3S00 (br), 2970 (br), 2940,
17S0, 1730 (br) cm"; IH NMR: 0.79 (d, IH,
J=2.S3, S-H), 1.0, 1.23, 1.31, 1.41, I.S1 (5xs, ISH,
5xCH3), 2.14 (s, 3H, COCH3), 2.56 (s, IH, 9-H),
2.63 (s, 2H, 12-H2), 3.39 (d, IH, J=4.0S, 7-H), 3.83
(d, 2H, J=5.06, CH2CI), 3.93, 4.14 [2xt, 2H,
Jgem=10.13,J=5.67, OCH2CH(OAc)], 4.33 (dd, IH,
J=4.05, 2.53, 6-H), 5.02 (dd, IH, Jcis=I1.14,
Jgem=1.82, IS-Hei.,), S.IS (dd, IH, .ftrans=17.2,
Jgem=1.82, IS-Hlrans), 5.06-S.34 [m, IH, CR(OAc)],
S.96 (dd, IH, .ftrans=17.2, Jeis=I1.14, 14-H). Anal.
Calcd for C2sH3906CI: C, 63.75; H, 8.35; CI, 7.S3.
Found: C, 62.84; H, ~A7; Cl, 7.62%.
7[>-(2-Acetoxy-3-chloropropyloxy)-8,13-epoxy-
la,6[3,9a-trihydroxylabd-14-en-ll-one 6. This
compound was prepared from 3 and AcOH by the
method described for the synthesis of compound 4.
The crude product was purified by flash
chromatography using 8% CH3CN in CHCh, yield
93.25%, semisolid; IR (KBr): 3500-3400 (br), 295S
(br), 1745, 172S crn"; IH NMR: 1.07, 1.29, 1.43
(6H), 1.63 (4xs, ISH, 5xCH3), 2.07 (br, IH, S-H),
2.13 (s, 3H, COCR3), 2044 (d, IH, Jgem=16.2, 12-
[3H), 3.11 (d, IH, Jgem=16.2, 12-aH), 3.77 (m, 3-H,
7-H and CH2Cl), 3.86-4.03 [m, 2H,
OCR2CH(OAc)-], 4041 (t, IH, J=3.04, 6-H), 4.S4
(br, IH, I-H), 4.96 (dd, IH, Jcis=11.l4, Jgem=1.82,
IS-Heis), 5.16 (dd, 1H, .ftram=17.21, Jgem= 1.82, 15-
Hlrans),5.11-5.31 [m, IH, CR(OAc)], 6.04 (dd, IH,
.ftran,=17.21, Jcis=11.l4, 14-H), 6.33 (br, IH,
exchangable, OH). Anal. CaJcd for C2sH390sCI: C,
59.69; H, 7.81; Cl, 7.05. Found: C, 59.51; H, 7.78;
Cl,7.15%.
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713-(2-Acetoxy-3-dimethylaminopropyloxy)-8,13-
epoxy-la,6~,9a-trihydroxylabd-14-en-ll-one 7.
Compound 6 (0.15 g, 0.3 mmol) was dissolved in
CH2Ch (2 mL) and a saturated solution of dimethyl
amine in toluene (0.2 mL) was added to it. The
reaction mixture was stirred at room temperature
for 12 h. Solvent was removed and the residue
purified by flash chromatography using 5% MeOH
in CHCh as eluent. The pure product was
converted to hydrochloride salt and recrystallized
from MeOH-dry ether, yield 0.045 g (29.4%), mp,
147-52 DC; IR (KBr): 3400-3300 (br), 2950 (br),
1755 (br), 1718 cm'; IH NMR: 1.07, 1.29, 1.43
(6-H), 1.64 (4xs, 15H, 5xCH3), 2.04 (d, IH, J=2.1,
5-H), 2.24 (s, 3H, COCH3), 2.38 (d, 1H, Jgem=16.2,
12-[3H), 2.89, 2.93 [2xs, 6H, N(CH3)2], 3.24 (d,
IH, Jgem=16.2, 12-aH), 3.44 (m, 2H, -CH2Cl), 3.79
(d, IH, J=4.05, 7-H), 3.91 [m, 2H,
OCH2CH(OAc)], 4.47 (br, 2H, I-H and 6-H), 4.94
(dd, IH, Jei.,·=ll.l, Jgem=1.2, 15-Heis), 5.13 (dd, 1H,
Jlrans=17.2, Jgem=1.8, 15-Hlrans), 5.33 [m, IH,
-CH(OAc)], 6.09 (dd, IH, .ftrans=17.2, Jci.,=ll.l,
14-H). Anal. Calcd for C27~6N08CI. 0.5 H20: C,
58.21; H, 8.49; N, 2.51; Cl, 6.36. Found: C, 58.08;
H, 8.66; N, 2.39; Cl, 6.44%.
6f3,9a-Dihydroxy-713-(3-dimethylamino-2-hydroxy-
propyloxy )-8,13-epoxy-l a-terti-arybutyldimethylsil-
yloxylabd-l4-en-11-one 8. Compound 1 (1.07 g; 2
mmol) was dissolved in CH2Ch (l0 mL) and a
saturated solution of dimethyl amine in toluene (2.5
mL) was added to it. The reaction mixture was
stirred at room temperature for 12 hr. Solvent was
removed and the residue purified by flash
chromatography using 5% MeOH in CHCh as
eluent. The pure product was crystallized from
EtOAc-light petroleum, yield 0.86 g (73.8%), mp,
155-57 DC; IR (KBr): 3520, 3360, 2980, 1725 (br),
cm "; IH NMR: 0.05, 0.16 [2xs, 6H, Si(CH3h],
0.97 [s, 9H, SiC(CH3)3], 1.07, 1.28, 1.44 (6H), 1.61
(4xs, 15H, 5xCH3), 2.07 (d, I H, J=3.04, 5H), 2.39
(d, IH, J);em=16.2, 12-[3H), 2.44 [s, 6H, N(CH3)2],
2.43-2.63 (m, 2H, CH2Cl), 3.21 (d, IH, J);em=16.2,
12-aH), 3.66, 3.94 (2xdd, IH, J);em=10.2, J=5.06,
OCH2CH(OH)-], 3.80-4.11 [m, 2H, 7-H and
-CH(OH)], 4.46 (t, I H, J=3.04, 6-H), 4.60 (br, IH,
I-H), 4.93 (dd, IH, Jus=IO.13, J);em=1.6, 15-R:i'),
5.09 (dd, IH, Jlrans=17.2, J);em=1.6, 15-Hlram), 6.18
(dd, I H, Jlrans=17.2, Jus= 10.13, 14-H). Anal. Calcd
for C3IHs7N07Si, H20: C, 61.84; H, 9.88; N, 2.33.
Found: C, 61.71; H, 9.59; N, 2.25%.
Compounds 9-11 were prepared by the same
method using 1 and the appropriate amine in
CH2CI2 at room temperature.
6[3,9a-Dihydroxy-713- (3-diethylamino-2-hydroxy-
propyloxy) -8,13-epoxy-la-tertiary-butyldimethyl-
silyloxy-labd-Ia-en-l l-one 9. Compound 1 was
treated with diethyl amine as described for 8. The
crude product was purified by flash
chromatography using 5% MeOH in CHCh as
eluent. The pure product was crystallized from
EtOAc-light petroleum, yield 96.6%; mp, 157-
60 DC; IR (KBr): 3340 (br), 2980, 2950, 1722 cm';
IH NMR: 0.03, 0.13 [2xs, 6H, Si(CH3)2], 0.89 [s,
9H, SiC(CH3)3], 1.06, 1.2?_pxs, 6H, 2xCH3), 1.28
(t, 6H, J=8.6, 2xNCH2CH3), 1.43 (s, 6H, 2xCH3),
1.60 (s, 3H, CH3), 2.34 (d, IH, J=3.04, 5-H), 2.36
(d, IH, Jgem=16.2, 12-~H), 3.07 (m, 6H,
2xNCH2CH3 and -CH2NEt2), 3.20 (d, IH,
Jgem=16.2, 12-aH), 3.51-4.17 [m, 4H, 7-H,
-OCH2CH(OH)-], 4.43 (t, IH, J=3.04, 6-H), 4.57
(br, IH, I-H), 4.91 (dd, IH, Jeis=lO.13, Jgem=1.6,
15-Hei.J, 5.06 (dd, IH, J1rans=17.2, Jgem=I.6, 15-
Hlrans), 6.13 (dd, IH, .ftrans=17.2, Jcis=10.13, 14-H).
Anal. Calcd for C33H6IN07Si: C, 64.77; H, 10.05;
N, 2.29. Found: C, 64.61; H, 9.95; N, 2.12%.
6[3,9a-Dihydroxy-S,13-epoxy-713-(3-piperidino-
2-hydroxypropyloxy) -la-tertiarybutyldimethyl-
silyloxylabd-14-en-ll-one 10. Compound 1 was
reacted with piperidine in dichloromethane as
described for the synthesis of 8. The crude product
was purified by flash chromatography using 5%
MeOH in CHCh as eluent. The pure product was
crystallized from EtOAc-light petroleum. Yield
90.9%; mp, 205-208 DC; IR (KBr): 3330 (br), 2960,
-I I .
1732 cm; H NMR: 0.0 I, 0.14 [2xs, 6H,
Si(CH3)2], 0.86 [s, 9H, SiC(CH3)3], 1.06, 1.26, 1.40
(6H), 1.60 (4xs, 15H, 5xCH3), 2.05 (d, IH, J=2.5,
5-H), 2.37 (d, IH, Jgem=16.2, 12-[3H), 2.70-2.94 (m,
4H, -CH2NCHr), 3.18 (d, IH, J);em=16.2, 12-aH),
3.34-4.23 [m, 6H, 7-H and -OCH2CH(OH)-
CH2N], 4.43 (t, IH, J=2.5, 6-H), 4.59 (br, IH, 1-
H), 4.91 (dd, IH, Jci,=11.l4, Jgem=1.6, 15-He;,),
5.07 (dd, IH, Jlrans=17.2, Jgem=I.6, 15-Hlrans), 6.14
(dd, IH, .ftrans=17.2, Jcis= 11.14, 14-H). Anal. Calcd
for C34H6IN07Si: C, 65.45; H, 9.86; N, 2.24.
Found: C, 65.29; H, 9.69; N, 2.12%.
6[3,9a-Dihydroxy-S,13-epoxy-713-(3-morpholino-2-
hyd roxypropyloxy )-1a-tertiarybutyldimethylsilyl-
oxylabd-l4-en-11-one 11. This was. prepared by
reacting 1 with morpholine. The crude product was
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purified by flash chromatography using 5% MeOH
in CHCb as eluent, yield 94.8% (semisolid); IR
(KBr): 3450 (br), 3330 (br), 2970, 1730 cm"; IH
NMR: 0.04,0.13 [2xs, 6H, Si(CH3)2], 0.89 [s, 9H,
SiCCCH3)3], 1.06, 1.26, 1.41 (6H), 1.60 (4xs, ISH,
5xCH3), 2.07 (d, lH, J=3.04, 5-H), 2.38 (d, IH,
Jgem=16.2, 12-I3H), 2AI-2.69 [m, 6H,
-CH(OH)CH2N- and CH2NCH2], 3.21 (d, IH,
Jgem=16.2, 12-aH), 3.54-4.0 [m, 8H, 7-H,
-OCH2CH(OH) and CH20CH2], 4A4 (t, 1H,
J=3.04, 6-H), 4.59 (br, IH, H-I), 4.91 (dd, IH,
Jci.,=IO.13, Jgem=1.6, 15-Hcis), 5.07 (dd, IH,
.ftrans=17.2, Jgem=1.6, IS-HIrons), 6.14 (dd, IH,
.ftrans=17.2, Jcis=10.13, 14-H). Anal. Calcd for
C33H59NOgSi: C, 63.32; H, 9.50; N, 2.24; Found:
C, 63.23; H, 9.69; N, 2.09%.
7f3-{2-Acetoxy-3-dimethyIaminopropyloxy)-6l3,9a-
dihydroxy-8,13-epoxy-l a-tertiarybutyldimethyl-
silyloxylabd-l4-en-ll-one 12. The compound 8
(0.86 g; 1.47 mmol) and DCC (0.72 g, 3.5 mmol)
were dissolved in EtOAc (10 mL) and AcOH (0.17
mL; 2.97 mmol) was added under vigorous stirring
at room temperature. After 5 min. DMAP (0.363 g,
3 mmol) was added and stirring continued for 4 h.
DCU was filtered off and the filtrate washed with
brine. The EtOAc layer was dried over anhydrous
Na2S04 and solvent removed. The residue was
purified by flash chromatography using 20%
CH3CN in CHCb as eluent, yield 0.822 g (89.2%),
(semisolid); IR (KBr): 3330 (br), 2965, 2945, 1750
(br) 1725 cm"; IH NMR: 0.01, 0.14 [2xs, 6H,
Si(CH3)2], 0.89 [s, 9H, SiCCCH3)3], 1.06, 1.26,
1.39, 1.43, 1.57 (5xs, 15H, 5xCH3), 2.08 (br, IH,
J=3.04, 5-H), 2.09 (s, 3H, COCH3), 2.31 [s, 6H,
N(CH3)2], 2.33 (d, IH, Jgem=16.2, 12-I3H), 2.57 [m,
2H, -CH2NMe2), 3.26 (d, 1H, Jgem= 16.2, 12-aH),
3.66-4.14 [m, 3H, 7-H, -OCH2CH(OH)], 4.43 (m,
IH, 6-H), 4.56 (br, IH, I-H), 4.90 (dd, IH,
Jcis=10.13, Jgem=1.7, 15-Hei.,), 5.09 (dd, IH,
.ftram=17.2, Jgem=1.7, 15-Hlrans), 5.0-5.29 [m, IH,
CH(OAc)], 6.09 (dd, IH, .ftrans=17.2,Jeis=IO.13, 14-
H). Anal. Calcd for C33H59NOgSi: C, 63.32; H,
9.50; N, 2.24. Found: C,63.16; H, 9.61; N, 2.06%.
Compounds 13-15 were prepared according to




silyloxylabd-l4-en-ll-one 13. This compound was
prepared by reacting 9 with AcOH by DCC-DMAP
method described for the synthesis of compound
12. The residue was purified by flash
chromatography using 20% CH3CN in CHCb as
eluent, yield 88% (EtOAc-light petroleum), mp,
76-78°C; IR (KBr): 3340 (br), 2955, 1753 (br),
1725 cm"; IH NMR: 0.06, 0.11 [2xs, 6H,
Si(CH3)2], 0.90 [s, 9H, SiCCCH3)3], 1.02 (t, 9H,
J=7.09, 2xCH2CH3 and CH3), 1.29, lAO, IA4,
1.57 (4xs, 12H, 4xCH3), 2.09 (s, 3H, eOCH3), 2.10
(br, IH, 5-H), 2.33 (d, IH, Jgem=lfj.2, 12-I3H), 2.59
(quartet, 4H, J=7.09, 2xNCH2CH3), 2.60 (br, 2H,
-CH2NEt2), 3.27 (d, IH, Jgem=16.2, 12-aH), 3.69,
3.99 [2xdd, 2H, Jgem=9.1, J=5.06 -OCH2CH(OH)],
3.76 (d, IH, J=4.05, 7-H), 4.41 (dd, IH, J=4.05
and 3.04, 6-H), 4.56 (br, IH, I-H), 4.89 (dd, IH,
Jcis=I1.I, Jgem=1.7, 15-Heis), 5.09 (dd, IH,
Jlram·=17.2, Jgem=1.7, 15-Hlram), 4.99-5.16 [m, IH,
-CH(OAc)], 6.07 (dd, IH, .ftrans=17.2, Jcis=I1.I,
14-H). Anal. Calcd for C35H63NOgSi:C, 66.09; H,
9.71; N, 2.14. Found: C, 65.89; H, 9.97; N, 1.95%.
7~(2-Acetoxy-3-piperidinopropyloxy) -613,9a-
dihydroxy-8,13-epoxy-la-tertiarybutyldimethyl-
silyloxylabd-l4-en-ll-one 14. Compound 14 was
prepared by reacting 10 with AcOH by DCC-
DMAP method described for the synthesis of
compound 12. The residue was purified by flash
chromatography using 20% CH3CN in CHCb as
eluent, yield 94%, semisolid; IR (Neat): 3330 (br),
2950, 1745, 1720 (br) cm"; IH NMR: 0.01, 0.13
[2xs, 6H, Si(CH3)2], 0.86 [s, 9H, SiCCCH3)3], 1.04,
1.26, 1.39, 1.43, 1.56 (5xs, ISH, 5xCH3), 1.20-2.0·
[m, 10H, 2-CH2, 3-CH2' NCH2(CH2)3-], 2.07 (br,
4H, COCH3 and 5-H), 2.31 (d, IH, Jgem=16.2, 12-
I3H), 2.31-2.63 [m, 6H, -CH(OAc)CH2N- and
-CH2NCH2-], 3.24 (d, IH, Jgem=16.2, 12-aH),
3.63, 3.94 (m, 3H, 7-H and -OCH2CH(OH)], 4A4
(br, IH, 6-H), 4.53 (br, IH, I-H), 4.89 (dd, IH,
Jcis=Il.l, Jgem=1.8, 15-Hei.,), 5.06 (dd, IH,
J1ron,=17.2, Jgem=I.8, 15-Hlram), 5.18 [m, IH,
-CH(OAc)], 6.10 (dd, IH, Jlrans=17.2, Jcis=I1.I,
14-H). Anal. Calcd for C36H63NOgSi:C, 64.92; H,
9.54; N, 2.10. Found: C, 64.97; H, 9.70; N, 1.99%.
7~(2-Acetoxy-3-morpholinopropyloxy)-613,9a-
dihydroxy-8,13-epoxy-l a-tertiarybutyldimethyl-
silyloxylabd-14-en-ll-one 15. Compound 15 was
prepared from 11 using the same method as
described for the synthesis of 12. The residue was
purified by flash chromatography using 10%
CH3CN in CHCb as eluent, yield ·89.8%,
semisolid; IR (Neat): 3430 (br), 2950, 1750, 1725
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(br) cm"; IH NMR: 0.01, 0.13 [2xs, 6H, Si(CH3)2],
0.86 [s, 9H, SiC(CH3)3], 1.04, 1.26, 1.37, 1.41, 1.54
(5xs, ISH, 5xCH), 2.06 (br, 4H, COCH3 and 5-H),
2.31 (d, IH, Jgem=16.2, 12-~H), 2.23-2.63 [m, 6H,
-CH(OAc)CHr and -CH2NCH2-], 3.26 (d, IH,
Jgem=16.2, 12-aH), 3.61-4.14 (m, 7H, 7-H,
-OCH2CH(OH), and -CH20CHr], 4.43 (br, 1H,
6-H), 4.54 (br, IH, I-H), 4.89 (dd, IH, Jcis=10.13,
Jgem=1.6, 15-R.;,), 5.05 (dd, IH, J'ran.,=17.2,
Jgem=1.6, 15-H,ran.,), 5.17 [m, IH, -CH(OAc)], 6.09
(dd, IH, J'rans=17.2, Jcis=lO.13, 14-H). Anal. Calcd
for C3SH6IN09Si: C, 62.89; H, 9.21; N, 2.09.
Found: C, 62.73; H, 9.11; N, 1.96%.
7~-(3-Dimethylaminopropyloxy-2-hydroxy)-
8,13-epoxy-1a,6~,9a-trihydroxylabd-14-en-11-one
16. The compound 8 (0.511 g, 0.86 mmol) was
dissolved in THF (30 mL) and 1M nEu4N+F- in
THF (1 mL, 1 mmol) added to it. The reaction
mixture was stirred for 5 min. Solvent was
removed and the residue purified by flash
chromatography using 10% MeOH in CHCh as
eluent. The pure product was dissolved in EtOAc,
and HCI in dry ether was added to it. The
precipitated white solid was filtered off and washed
with dry ether. It was finally crystallized from dry
MeOH-dry ether, yield 0.28 g (63%), mp, 280-
82 DC (d); IR (KBr): 3520 (br), 2960 (br), 1720,
1725 (br) cm"; IH NMR(CDCI3+ CD30D): 1.07,
1.30, 1.44 (6H), 1.66 (4xs, ISH, 5xCH3), 2.06 (d,
IH, J=3.04, 5-H), 2.38 (d, IH, Jgem=16.2, 12-~H),
2.96, 2.99 (2xs, 6H, 2xNCH3), 3.29 (d, IH,
Jgem=16.2, 12-aH), 3.20-3.39 [m, 3H, CH2NMe2
and -CH(OH)], 3.81 (m, 3H, 7-H, and
OCH2CH(OH)-], 4.07-4.51 (m, 2H, I-H and 6-H),
4.94 (dd, IH, Jcis=10.I3, Jgem=1.6, I5-R·is), 5.14
(dd, IH, Jlran.,=17.2, Jgem=1.6, 15-H,rans), 6.14, 6.15
(2xdd*, IH, J,ram=17.2, Jcis=10.13, 14-H, *due to
diastereomers). Anal. Calcd for C2sH44N07Cl: C,
59.33; H, 8.76; N, 2.77; Cl, 7.01. Found: C, 59.23;
H, 8.71; N, 2.80; CI, 7.18%.
7~(3-Diethylaminopropyloxy-2-hydroxy)-8,13-
epoxy-1a,6~,9a-trihydroxy-labd-14-en-11-one 17.
Compound 17 was prepared from 9 using the same
method as described for the synthesis of 16. The
crude product was purified by flash chrornato-
graphy using 8% CH3CN in CHCI3 as eluent. The
pure product was converted to hydrochloride salt. It
was finally crystallized from dry MeOH-dry ether,
yield 61.9%, mp, 207-12DC (dry MeOH-dry ether);
IR (KBr): 3500-3200 (br), 2950 (br), 1720, (br)
cm", IH NMR: 1.23,1.31 (2xs, 6H, 2xCH3), 1.41
(t, 6H, J=7.1, 2xCH2CH3), 1.43 (6H), 1.67 (2xs,
9H, 3xCH3), 2.05 (d, IH, J=2.5, 5-H), 2.41 (d, IH,
Jgem=16.2, 12-~H), 3.16-3.34 (m, 7H, 12-aH,
2xNCH2CH3 and CH2NEt2), 3.81 (m, 3H, 7-H and
OCH2CH(OH)-], 4.20-4.54 [m, 3H, IH, 6-H and
CH(OH)-], 4.94 (dd, IH, Jci.,=1l.1, Jgem=1.2, 15-
H.ci.,),5.13 (dd, 1H, J'rans=17.2, Jgem=1.2, 15-H,rans),
6.10,6.13 (2xdd*, IH, J,ram=17.2, Jcis=I1.1, 14-H,
*due to diastereomers). Anal. Calcd for
C27H4sN07Cl: C, 60.71; H, 9.06; N, 2.62; Cl, 6.64.
Found: C, 60.55; H, 9.16; N, 2.32; Cl, 6.73%.
8,13-Epoxy-7~(2-hydroxy-3-piperidinopropyl-
oxy)-la,6~,9a-trihydroxylabd-14-en-11-one 18.
This was prepared from 10 using the same method
as described for the synthesis of 16. The crude
product was purified by flash chromatography
using 8% CH3CN in CHCh as eluent. The pure
product was converted to hydrochloride salt. It was
finally crystallized from dry MeOH-dry ether, yield
75.7%, mp, 225 DC (d) (dry MeOH-dry ether), IR
(KBr): 3555,3245 (br), 2950, 1695 (br) cm"; IH
NMR (CDCh + CD30D): 1.06 (br, 5H, CI:I3and 4/-
CH2 of piperidine), 1.27, 1.40 (6H), 1.64 (3xs,
12H, 4xCH3), 2.03 (d, IH, J=3.04, 5-H), 2.40 (d,
1H, Jgem= 16.2, 12-~H), 3.17 (br, 4H, -CH2NCH2-),
3.23 (d, IH, Jgem=16.2, 12-aH), 3.51-3.87 [m, 4H,
7-H and -CH(OH)CH2N-], 4.21-4.53 [m,4H, I-H,
6-H and -OCH2CH(OH)-], 4.94 (dd, IH, Jci.,=11.1,
Jgem=1.8, I5-Hcis), 5.13 (dd, 1H, .ftrans=I7.2,
Jgem=1.8, I5-H,rans), 6.10, 6.13 (2xdd*, IH,
J'ran.,=17.2, Jci.,=I1.1, 14-H, *due to diastereomers).
Anal. Calcd for C2sH4sN07CI: C, 61.58; H, 8.86;




This was prepared from 11 using the same method
as described for the synthesis of 16. The crude
product was purified by flash chromatography
using 8% CH3CN in CHCl3 as eluent. The pure
product was converted to hydrochloride salt. It was
finally crystallized from dry MeOH-dry ether, yield
73.5%, mp, 240-43 DC (d) (dry MeOH-dry ether);
IR (KBr): 3300 (br), 2960 (br), 1705 (br) cm"; IH
NMR (CDCh+CD30D): 1.09 1.31, 1.46 (6H), 1.67
(4xs, ISH, 5xCH3), 2.06 (d, IH, J=2.7, 5-H), 2.38
(d, IH, Jgem=16.2, 12-~H), 3.19-3.37 (m, 4H,
-CH2NCH2-), 3.28 (d, IH, Jgem=16.2, 12-aH),
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3.44-3.83 [m, 4H, 7-H and -CH(OH)CH2N-], 4.0
(br, 4H, -CH20CH2-), 4.29-4.51 [m,4H, I-H, 6-H
and -OCH2CH(OH)-], 4.95 (dd, IH, Jei,=11.1,
Jgem=1.8, IS-Hei,), 5.15 (dd, IH, Jrrans=17.2,
Jgem=1.8, IS-Hrram), 6.14, 6.15 (2xdd*, IH,
Jrrans'=17.2, Jci,,= 11.1, 14-H, *due to diastereomers).
Anal. Calcd for C28H46NOgCI,0.S H20: C, 58.21;
H, 8.49; N, 2.51; CI, 6.36. Found: C, 58.51; H,
8.48; N, 2.60; CI, 6.47%.
7~(2-Acetoxy-3-dimethylaminopropyloxy)-8,13-
epoxy-la,613,9a-trihydfoxylabd-l4-en-ll-one 7.
This compound was also prepared from 12 using
the method described for the synthesis of 16. The
crude product was purified by flash chromato-
graphy using 20% CH3CN in CHCI3 as eluent. The
pure product was converted to hydrochloride salt. It
was finally crystallized from dry MeOH-dry ether,
yield 71.6%, (mp, JR, IH NMR data and analyses
have been given earlier).
713-(2-Acetoxy-3-piperidinopropyloxy)-8,13-
epoxy-la,613,9a-trihydroxylabd-l4-en-l1-one 20.
This was prepared from 14 according to the method
as described for the synthesis of 16. The crude
product was purified by flash chromatography
using 8% CH3CN in CHCh as eluent. The pure
product was converted to hydrochloride salt. It was
finally crystallized from dry MeOH-dry ether, yield
68%; mp, 158-60°C (dry MeOH-dry ether); IR
(KBr): 3500-3100 (br), 2960 (br), 1765, 1755 (br),
1725 crn"; IH NMR: 1.06 1.26, 1.40 (6H), 1.61
(4xs, I5H, 5xCH3), 1.60-1.92 [m, 6H, 3-CH2' 4-
CH2, 5-CH2 of piperidine), 2.04 (d, IH, J=2.7, 5-
H), 2.17 (s, 3H, COCH3), 2.39 (d, 1H, Jgem=16.2,
12-I3H), 2.61-3.0 (m, 4H, CH2NCH2), 3.21 (d, IH,
J}:em=16.2, 12-aH), 3.34-4.0 [m, 5H, 7-H and
-CH2CH(OAc)CH2N-], 4.0 (br, 4H, -CH20CHr),
4.53 (br, 2H, I-H and 6-H), 4.92 (dd, IH,
Jci,=10.13, Jgem=2.0, 15-Hci')' 5.13 (dd, IH,
Jrrans=17.2, J}:em=2.0, 15-Hrrans), 5.43 [m, 1H,
-CH(OAc)], 6.04, 6.07 (2xdd*, IH, Jrrans=17.2,
Jei,=10.13, 14-H, *due to diastereomers). Anal.
Ca1cd for C30HsoNOgCI, 0.5 H20: C, 60.33; H,
8.62; N, 2.35; CI, 5.94. Found: C, 60.32; H, 8.76;
N, 2.30; CI, 6.12%.
7~(2-Acetoxy-3-morpholinopropyloxy)-8,13-
epoxy-l a,613,9a-trihydroxylabd-l4-en-l1-one 21.
This was prepared from 15 according to the method
as described for the synthesis of 16. The crude
product was purified by flash chromatography
using 8% CH3CN in CHCb as eluent. The pure
product was converted to hydrochloride salt. It was
finally crystallized from dry MeOH-dry ether,
yield 69.9%, mp, 203-07 °C (dry MeOH-dry ether);
IR (KBr): 3400-3225 (br), 2940 (br), 1755, 1710
cm"; IH NMR: l.10 1.30, 1.46 (6H), 1.64 (4xs,
15H, 5xCH3), 2.05 (d, IH, J=3.04, 5-H), 2.24 (s,
3H, COCH3), 2.41 (d, IH, Jgem=16.2, 12-I3H), 2.94
(m, 4H, CH2NCH2), 3.22 (d, 1H, Jgem=16.7, 12-
aH), 3.43 [m, 2H, -CH(OAc)CH2N-], 3.77-4.11
(m, 5-H, 7-H and CH20CH2), 4.23 (m, 2H,
OCH2CH-], 4.57 (br, 2H, 1-H and (i-H), 4.95 (dd,
IH, Je",=I1.I, Jgem=1.8, 15-Hei'), 5.14 (dd, 1H,
Jrram·=17.2, Jgem=1.8, 15-Hrram), 5.47 [m, IH,
-CH(OAc)], 6.05, 6.10 (2xdd*, IH, Jrran.l=17.2,
Jci,·=IO.13, 14-H, *due to diastereomers). Anal.
Ca\cd for C29~gN09CI: C, 59.02; H, 8.19; N, 2.37;
CI, 6.01. Found: C, 58.83; H, 8.27; N, 2.30; CI,
6.15%.
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